Product Code: IRTNTR12318
About dPCR
Digital polymerase chain reaction (dPCR) technology is an advanced version of the polymerase chain reaction (PCR) technology that enables users to amplify and directly quantify nucleic acids, such as DNA, RNA, cDNA, and methylated DNA with a high level of precision. The technique allows users to statistically analyze PCR products by converting exponential, analog signals obtained from conventional PCR technology to linear and digital signals.
Technavio's analysts forecast the global dPCR market to grow at a CAGR of 10.1% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global dPCR market for 2017-2021. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.
The market is divided into the following segments based on geography:
Technavio's report, Global dPCR Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
- Bio-Rad Laboratories
- Fluidigm
- RainDance Technologies
- Thermo Fisher Scientific
Other Prominent Vendors
- Becton, Dickinson and Company
- Exiqon
- Formulatrix
- Promega Corporation
- Sigma-Aldrich
- Stilla Technologies
Market driver
- Rising focus on disease diagnosis and drug discovery and development.
- For a full, detailed list, view our report
Market challenge
- Stringent government rules and regulations.
- For a full, detailed list, view our report
Market trend
- Rising prominence of PCR solutions in biomedical sector.
- For a full, detailed list, view our report
Key questions answered in this report
- What will the market size be in 2021 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.
Table of Contents
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Research Methodology
PART 04: Introduction
PART 05: Market landscape
- Market overview
- Market size and forecast
- Five forces analysis
PART 06: Market segmentation by product type
PART 07: Market segmentation by geography
PART 08: Decision framework
PART 09: Drivers and challenges
- Market drivers
- Impact of drivers on key customer segments
- Market challenges
- Impact of challenges on key customer segments
PART 10: Market trends
PART 11: Vendor landscape
PART 12: Key vendor analysis
- Bio-Rad Laboratories
- Fluidigm
- RainDance Technologies
- Thermo Fisher Scientific
- Other prominent vendors
PART 13: Appendix
List of Exhibits
- Exhibit 01: Growth trend of pharmaceutical market 2008-2018
- Exhibit 02: Global dPCR market: Key impacting factors
- Exhibit 03: Advantages of dPCR solutions
- Exhibit 04: Global dPCR market segmentation by application 2016 and 2021
- Exhibit 05: Global dPCR market 2016-2021 ($ billions)
- Exhibit 06: Five forces analysis
- Exhibit 07: Global dPCR market segmentation by product type 2016 and 2021
- Exhibit 08: Global dPCR market: Opportunity analysis
- Exhibit 09: dPCR market by consumables 2016-2021 ($ billions)
- Exhibit 10: dPCR market by instruments 2016-2021 ($ billions)
- Exhibit 11: Value-chain of laboratory instruments
- Exhibit 12: Global dPCR market segmentation by geography 2016 and 2021
- Exhibit 13: Snapshot of geographical segmentation 2016-2021
- Exhibit 14: dPCR market in Americas 2016-2021 ($ billions)
- Exhibit 15: dPCR market in EMEA 2016-2021 ($ billions)
- Exhibit 16: Impact of BREXIT on the laboratory equipment market
- Exhibit 17: dPCR market in APAC 2016-2021 ($ billions)
- Exhibit 18: Pharmaceutical R&D spending in US and Europe
- Exhibit 19: Impact of drivers
- Exhibit 20: Impact of challenges
- Exhibit 21: Key investment sectors 2015
- Exhibit 22: Region-wise growth in R&D spending in biomedical sector 2010-2015
- Exhibit 23: Strategic success factor of companies
- Exhibit 24: Competitive parameters in global dPCR market
- Exhibit 25: Bio-Rad Laboratories: Product offerings
- Exhibit 26: Bio-Rad Laboratories: Key takeaways
- Exhibit 27: Fluidigm: Product offerings
- Exhibit 28: Fluidigm: Key takeaways
- Exhibit 29: RainDance Technologies: Product offerings
- Exhibit 30: RainDance Technologies: Key takeaways
- Exhibit 31: Thermo Fisher Scientific: Product offerings
- Exhibit 32: Thermo Fisher Scientific: Key takeaways
